AbCellera has announced the appointment of Victor Sandor, M.D. C.M, to its Board of Directors as an independent director.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one ...

The shape of that competition is given physical form at the 2026 BIO International Convention (BIO 2026) in San Diego, ...

Multiple sclerosis is especially destructive because of its tendency to worsen progressively. Instead of working through the immune system, Quantum BioPharma’s Lucid-MS acts directly on the myelin ...

Now, Quantum BioPharma Ltd. is challenging that reality. The company is advancing Lucid-MS, a patented, first-in-class drug candidate that takes a fundamentally different approach by directly ...

Ambrosia Biosciences Inc., named after the drink of the Greek gods, secured a $100 million series B to advance its preclinical pipeline of oral obesity drugs. The startup formed after Pfizer Inc.

This year, my company celebrates its 50th anniversary as a partner to scientists and innovators. The company was started in 1976, and strategic acquisitions and changes over the past decade, including ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. ArriVent BioPharma, Inc. (AVBP Quick Quote AVBP - Free Report) is a stock that can ...

March 24 (Reuters) - Spanish drugmaker Grifols (GRLS.MC), opens new tab said on Tuesday it has approved a U.S. initial ‌public offering of its U.S. biopharma business. Grifols, which makes drugs using ...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved ...

Venture capital funding is showing a preference for more certain scores, with median early-stage funding value rising 77% from last year. (iStock / Getty Images Plus) Just as a disciplined a soccer ...